Strategies for the treatment and prevention of cytomegalovirus infections
- 1 January 1993
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 3 (3) , 187-204
- https://doi.org/10.1016/0924-8579(93)90012-t
Abstract
No abstract availableKeywords
This publication has 130 references indexed in Scilit:
- Activity of the anti-HIV agent 9-(2-phosphonyl-methoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivoEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Activity of different antiviral drug combinations against human cytomegalovirus replication in vitroEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirusEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Progrediente Zytomegalie-Enzephalitis unter erfolgreicher Ganciclovir-Therapie einer Zytomegalie-Retinitis bei einem AIDS-PatientenJournal of Molecular Medicine, 1991
- Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised PatientsNew England Journal of Medicine, 1989
- Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant RecipientsNew England Journal of Medicine, 1987
- Development of Cytomegalovirus (CMV) Retinitis in a Patient with AIDS during Ganciclovir Therapy for CMV ColitisNew England Journal of Medicine, 1987
- Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow TransplantationNew England Journal of Medicine, 1986
- Treatment of Serious Cytomegalovirus Infections with 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine in Patients with AIDS and Other ImmunodeficienciesNew England Journal of Medicine, 1986
- Prevention of transfusion-acquired cytomegalovirus infections in newborn infantsThe Journal of Pediatrics, 1981